Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
Article in Lung Cancer (March 2024)
The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.
Article in Lung Cancer (March 2024)
Article in npj Precision Oncology (January 2024)
Article in Cancer Medicine (January 2024)